Gefitinib Biogaran

Gefitinib Biogaran is an oral medication used for targeted therapy in certain types of cancer. This pharmaceutical is manufactured by Biogaran and is available in the EU market.

Gefitinib Biogaran is primarily used in the treatment of specific types of cancer, particularly non-small cell lung cancer. It works by targeting certain proteins that help cancer cells grow and divide. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its role as a targeted therapy for cancer treatment.

Common effects of Gefitinib Biogaran may include skin rash, diarrhea, and fatigue. Some patients may also experience nausea or loss of appetite. These effects can vary from person to person and are not exhaustive.

Gefitinib Biogaran should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication.

Gefitinib Biogaran may interact with other medications, including those that are metabolized by the liver. It is advisable to consult a healthcare professional before combining it with other treatments. Alcohol and certain foods may also affect its efficacy.